Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

6 Stock Charts To Watch: CODX, GILD, MRNA, NVAX, RAD, ZYXI

Published 03/18/2020, 08:19 AM
Updated 07/09/2023, 06:31 AM

1. Co-Diagnostics (NASDAQ:CODX) popped and pulled back on Tuesday, gaining 1.59, or 17 1/2%, to 10.68, after reaching a high of 13.00, on 18 million shares traded, and then traded another 24 cents or 2.25%, in after-hours. It closed way off the high. Nevertheless, it’s still in a wedge pattern. If it’s going to pop at some point, it’s going to break, possibly it could be in the high 20’s, low 30’s, even 40 or 50 at some point. We don’t know what’s going to happen yet. But, for now, it’s something to watch.

2. Gilead Sciences (NASDAQ:GILD) reversed beautifully on Tuesday, jumping 5.62, or 8.16%, to 74.52, with a high of 76.08, on 28.8 million shares traded. I don’t know why it got below 64-65 on Monday. There’s resistance around the 78-80 zone. If it can get through that, the target is 85-86.

3. Moderna (NASDAQ:MRNA) broke through the declining topsline slightly on Monday, exploding 1.69, or 6.38%, to 28.18, with a high of 32.70, on 44.5 million shares traded, and then pulled back, much like CODX. It looks to me like some of these stocks are losing their momentum but can easily pick it up. The volume was heavy on Tuesday, and it did break through a double top before backing off, so it might be an entry opportunity. Resistance now is 30 and 33, and then we’ll see what happens beyond that.

4. Novavax (NASDAQ:NVAX) had a good day on Tuesday, jumping 2.59, or 37 1/2%, to 9.50, with a high of 10.18, on 11.6 million shares traded. It snapped back to resistance, so we’ll have to see if it will take out 10 3/4. If it can, then I’m looking at 12 1/2 and 13 as targets.

5. Rite Aid (NYSE:RAD) really acted well on a snap back on Tuesday, gaining 3.83, or 29%, to 16.95, just a nickel off the session high at 17, on 10.4 million shares traded. Even before the market rallied, it went from 9 1/4, all the way up to 17, almost doubling. It’s at resistance. If it can get through here, you’re looking at 19 and 22 going forward.

6. Zynex (NASDAQ:ZYXI) had a nice reversal on Tuesday, popping 2.24, or 24%, to 11.59, on 341,659 shares traded. This stock came all the way down to 7.93 on Monday, and then went all the way up back up to Tuesdays high at 11.67. I look for this to retest the highs at 14 3/4. Beyond that, the target is 17.

Stocks on the long side included Agilent Technologies, Inc. (NYSE:A), Air Transport Services Group, Inc. (ATSG), Blue Apron Holdings, Inc. (APRN), Co-Diagnostics, Inc. (CODX), Gilead Sciences, Inc. (GILD), Genprex, Inc. (GNPX), Direxion Daily Junior Gold Miners Index Bull 3X Shares (JNUG), Direxion Daily Gold Miners Index Bull 3X Shares (NUGT), Moderna, Inc. (MRNA), Novavax, Inc. (NVAX), Rite Aid Corporation (RAD), Teladoc Health, Inc. (TDOC), United Natural Foods, Inc. (UNFI), Xencor, Inc. (XNCR), and Zynex, Inc. (ZYXI).

On the short side, stocks included Aaron's, Inc. (AAN), Aramark (ARMK), Boot Barn Holdings, Inc. (BOOT), Core Laboratories (CLB), Copa Holdings, S.A. (CPA), Crocs, Inc. (CROX), Discover Financial Services (NYSE:DFS), Dunkin' Brands Group, Inc. (DNKN), BRP Inc. (DOOO), Darden Restaurants, Inc. (NYSE:DRI), Expedia Group, Inc. (NASDAQ:EXPE), Group 1 Automotive, Inc. (GPI), Knoll, Inc. (KNL), Six Flags Entertainment Corporation (SIX), and Skechers U.S.A., Inc. (SKX).

Watch video here...

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.